Unloxcyt

cosibelimab-ipdl

Approval

ApplicationBLA 761297
Approval dateDec 13, 2024
Approval year2024
SponsorCheckpoint Therapeutics INC

FDA-approved use

To treat cutaneous squamous cell carcinoma

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Unloxcyt: